大分割胸部放疗中放射性肺炎与食管炎的剂量学预测因素
研究纳入2014年1月至2021年7月间47例体能状态差、合并症多的非小细胞肺癌患者,回顾性分析其接受中度大分割放疗的剂量学参数与急性放射性肺炎及食管炎的关系。探索性分析提示V10、V18及平均肺剂量与肺炎风险升高相关,平均肺剂量大于9.2 Gy时线性回归确认该关联(P = .050),最大剂量为食管炎的显著预测因素(P = .020)。作者指出样本量小限制了结论深度,需更大队列研究验证。
要点
- 47例中8例(17%)发生各级肺炎,4例(9%)发生CTCAE≥2级肺炎。
- 47例中26例(55%)发生各级食管炎,10例(21%)发生CTCAE≥2级食管炎。
- 平均肺剂量大于9.2 Gy与肺炎风险升高相关(P = .050),最大剂量为食管炎显著预测因素(P = .020)。
核心结论
- 平均肺剂量和最大剂量分别是肺炎和食管炎的显著预测因素,但样本量小限制了结论深度,需更大队列研究验证。
研究设计与样本
- 回顾性研究纳入2014年1月至2021年7月间47例体能状态差、合并症多的非小细胞肺癌患者,接受中度大分割放疗。
- 分析平均肺剂量、不同剂量水平的肺体积百分比、平均心脏剂量、心脏体积百分比、平均食管剂量及食管体积百分比等剂量学参数。
- 急性放射性肺炎在治疗后6个月内评估,急性放射性食管炎在治疗后3个月内评估。
- 统计分析采用随机森林、二元逻辑回归和线性回归。
主要发现
- 47例中8例(17%)发生各级肺炎,4例(9%)发生CTCAE≥2级肺炎。
- 47例中26例(55%)发生各级食管炎,10例(21%)发生CTCAE≥2级食管炎。
- 探索性分析提示V10、V18和平均肺剂量值与肺炎风险升高相关。
- 线性回归确认平均肺剂量大于9.2 Gy与肺炎风险相关(P = .050)。
- 对侧肺V5和V10值较高与肺炎风险较高相关(P = .013/P = .032)。
关键数值与推荐
- 肺炎风险相关剂量学参数:V10、V18、平均肺剂量(大于9.2 Gy时P = .050)、对侧肺V5(P = .013)和对侧肺V10(P = .032)。
- 食管炎风险相关剂量学参数:最大剂量(P = .020),EV5和EV40可能预示食管炎发生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 样本量小限制了结论深度。
- 需更大队列研究验证这些观察结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The proliferation rates of non-small cell lung cancer (NSCLC) and associated radiation resistance highlight the potential of hypofractionated radiation therapy (hypoRT). However, radiation pneumonitis and esophagitis remain dose-limiting adverse events. This study investigates dosimetric factors influencing the risk of pneumonitis and esophagitis in highly multimorbid patients undergoing moderately hypoRT. METHODS AND MATERIALS: Forty-seven NSCLC patients with poor performance status treated between January 2014 and July 2021 were included. Dosimetric parameters including mean lung dose (MLD), percentage of normal (ipsi-/contralateral) lung volume (Vx) receiving ≥x Gy (x = 20, 18, 10, and 5 Gy); mean heart dose (MHD), percentage of the heart volume (HVx) receiving ≥x Gy (x = 20, 10, and 5 Gy); and mean esophageal dose (MED), percentage of esophagus volume (EVx) receiving ≥x Gy (x = 40, 30, 20, 18, 10, and 5 Gy) were analyzed retrospectively. Acute radiation pneumonitis/esophagitis events were assessed within 6/3 months posttreatment. Statistical analyses included random forests, binary logistic regression, and linear regression. RESULTS: Among the 47 patients with compromised lung function and poor prognostic factors, 8 (17%) and 26 (55%) patients developed all-grade pneumonitis or esophagitis, while 4 (9%) and 10 (21%) patients developed CTCAE grade ≥2 pneumonitis and esophagitis, respectively. Exploratory analyses suggest that V10, V18, and MLD values are associated with an increased risk of pneumonitis. Linear regressions confirmed this for MLD values greater than 9.2 Gy (P = .050). Additionally, higher V5 and V10 values in the contralateral lung were associated with a greater risk of pneumonitis (P = .013/P = .032). Dmax proved to be a significant predictor of esophagitis (P = .020). Moreover, evidence suggests that EV5 and EV40 may portend esophagitis onset. CONCLUSIONS: This study provides insights into dosimetric factors influencing pneumonitis/esophagitis development in NSCLC patients undergoing hypoRT. While MLD and Dmax emerged as significant predictors of pneumonitis and esophagitis, the small sample size limited the depth of conclusions. Further research with larger cohorts is warranted to validate these observations, potentially optimizing treatment planning and outcomes in this challenging patient population.
引用
- Kenndoff S, Nieto A, Guggenberger JE, et al. Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors. Adv Radiat Oncol. 2024. PMID: 39896724. doi:10.1016/j.adro.2024.101682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。